BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 23623582)

  • 1. Chronic inflammatory demyelinating polyradiculoneuropathy.
    Van den Bergh PY; Rajabally YA
    Presse Med; 2013 Jun; 42(6 Pt 2):e203-15. PubMed ID: 23623582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
    Eftimov F; van Schaik I
    Curr Opin Neurol; 2013 Oct; 26(5):496-502. PubMed ID: 23852276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Dyck PJB; Tracy JA
    Mayo Clin Proc; 2018 Jun; 93(6):777-793. PubMed ID: 29866282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
    Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of IVIg in autoimmune neuropathies: the latest evidence.
    Hughes R
    J Neurol; 2008 Jul; 255 Suppl 3():7-11. PubMed ID: 18685920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy.
    Chan YC; Allen DC; Fialho D; Mills KR; Hughes RA
    J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):114-6. PubMed ID: 16361609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
    Tracy JA; Dyck PJ
    Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic inflammatory demyelinating polyradiculoneuropathy: clinical heterogeneity and therapeutic perspectives].
    Leger JM; Bombelli F; Tran-Thanh H; Chassande B; Maisonobe T; Viala K
    Bull Acad Natl Med; 2010; 194(4-5):753-64; discussion 764-5. PubMed ID: 21568049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of chronic inflammatory demyelinating polyneuropathy.
    Rotta FT; Sussman AT; Bradley WG; Ram Ayyar D; Sharma KR; Shebert RT
    J Neurol Sci; 2000 Feb; 173(2):129-39. PubMed ID: 10675657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune-mediated neuropathies: indications and value of nerve biopsy].
    Verschueren A
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S58-60. PubMed ID: 18087231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammatory demyelinating polyneuropathy.
    Said G
    Neuromuscul Disord; 2006 May; 16(5):293-303. PubMed ID: 16631367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Nobile-Orazio E; Gallia F
    Curr Opin Neurol; 2015 Oct; 28(5):480-5. PubMed ID: 26203970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
    Névoret ML; Vinik AI
    J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Samarasekera S
    Eur J Neurol; 2010 Jul; 17(7):939-44. PubMed ID: 20158514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of chronic inflammatory polyradiculoneuropathy].
    Nicolas G
    Rev Med Interne; 2008 Jun; 29 Spec No 2():1-8. PubMed ID: 18927988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
    Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
    Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
    Dalakas MC
    J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants.
    De Lorenzo A; Liberatore G; Doneddu PE; Manganelli F; Cocito D; Briani C; Fazio R; Mazzeo A; Schenone A; Di Stefano V; Cosentino G; Marfia GA; Benedetti L; Carpo M; Filosto M; Antonini G; Clerici AM; Luigetti M; Matà S; Rosso T; Lucchetta M; Siciliano G; Lauria Pinter G; Cavaletti G; Inghilleri M; Cantisani T; Notturno F; Ricciardi D; Habetswallner F; Spina E; Peci E; Salvalaggio A; Falzone Y; Strano C; Gentile L; Vegezzi E; Mataluni G; Cotti Piccinelli S; Leonardi L; Romano A; Nobile-Orazio E;
    Eur J Neurol; 2024 Apr; 31(4):e16190. PubMed ID: 38165011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.